Babson Diagnostics, an Austin-based diagnostic blood firm, is using a new blood sample collection technology called BetterWay at more than 25 collection sites in the Austin and Temple, Texas, area.

The company is scaling up manufacturing and commercial activities as it prepares to enter the U.S. market via the Food and Drug Administration’s de novo pathway.

The global blood collection devices market is set to grow from USD 9.13 billion in 2025 to USD 13.02 billion by 2030, with a CAGR of 7.4%. Factors driving market growth include the increasing ...

Seven Sam's Club pharmacies in the Austin, Texas, area are taking part in a pilot program that tests people's blood for uses such as possible reactions to GLP-1, the popular weight loss drug.

The World Indoor Championships air live on NBC Sports and Peacock through Sunday in Torun, Poland.

In a study published in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of Health and ...

Humans evolved in an atmosphere containing roughly 200–300 parts per million (ppm) of carbon dioxide (CO₂). Today, that ...

In a study published today in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of ...

Rhythm Biosciences has reached a major milestone with the first commercial sale of its blood-based ColoSTAT colorectal cancer ...

Brunei the orangutan is a good sport when Dr. Lily Parkinson draws some blood. “I'm finding his blood vessel on the ...